NR0B1 and congenital adrenal hyperplasia: The present findings broaden the molecular landscape of NR0B1 variants and underscore the relevance of early genetic testing to differentiate X-hypoAC from congenital adrenal hyperplasia, optimize long-term clinical management, and provide accurate genetic counseling for affected families.